Close
ACHEMA MIDDLE EAST 2026

Getting Immunotherapy Work In Case of Pancreatic Cancer

One of the latest studies that takes into account the tumour microenvironment of pancreatic cancer puts forth the cause that tumour cells are resistant...

Monoclonal Antibodies Ideal Against Malaria- Suggests Study

Only one dose of the monoclonal antibody (mAb) CIS43LS gave out high levels of protection against Malaria in challenge study as per new research....

A New UK Manufacturing Regulatory Framework On The Cards

As UK will introduce a customised framework for the innovative medicines’ regulation manufactured at the point where the care is received by the patient,...

With Discovery, Skullcap A Perfect Fit For Modern Medicine

A collaboration between Chinese researchers and UK researchers has led to the unlocking of facilities related to evolutionary secrets that help the medicinal herb...

High Mortality Due To VEXAS Than What Was Previously Thought

As per a recent study that was published in JAMA, a not so well-known syndrome with high mortality has a much higher prevalence than...

WHO Asks For Supply Chain Alterations To Fight Contamination

The World Health Organization has urged regulators, suppliers, as well as medicine manufacturers to take strict steps against medicines in the supply chain that...

Large DNA Sequences Insertion With New Method A Success

Recent work by researchers at Massachusetts General Hospital (MGH) in the US has improved the accuracy of inserting long DNA fragments into genomes. This method...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...